Westover Capital Advisors, LLC Exelixis, Inc. Transaction History

Westover Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$17.68 - $22.65 $189,529 - $242,807	-10,720 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$18.93 - $24.75 $300,665 - $393,104	-15,883 Reduced 59.7%	10,720 $229,000
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $283,220 - $357,782	14,450 Added 118.9%	26,603 $633,000
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $165,888 - $264,935	12,153 New	12,153 $239,000

564

251M

1.45M

1.13M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Westover Capital Advisors, LLC with notifications on news.